Observational studyBMC infectious diseases2018

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA).

Lucia Taramasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.